About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
D
Tirzepatide for Type 2 Diabetes
By
Diana Isaacs
10 Videos
6,601 views
August 23, 2022
6 Comments
Login to view comments.
Click here to Login
Featured Video
46:20
Lilly Diabetes
A Journey Through Clinical Efficacy and Safety Data Comparing Two In…
Feat.
S. Shadid
Featured Video
15:01
Lilly Diabetes
Discover the MOA of an Incretin Medication for T2D
Related Content
AUTOPLAY
ON
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments
Primer on Diabetes Management
Feat.
S. Inzucchi
17:21
Ilene Fennoy
Obesity and Diabetes in Children
34:49
Scripps Health
Medications for Weight Loss: The New Satiety Hormones
Feat.
K. Fujioka
18:43
ASPC 2019 Congress on CVD Prevention
Diabetes Treatment Guidelines Finally Have Entered the 21st Century …
Feat.
R. DeFronzo
15:06
Robert Busch
GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!
12:26
Juan Frias
SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide
15:33
Ken Fujioka
Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…
08:46
Robert Busch
FLOW Trial Results: GLPs, the Kidneys, and Even More to Come!!
27:24
Cardiometabolic Health Congress (CMHC)
SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes
Feat.
L. Sloan
26:49
Diana Isaacs
Tirzepatide Updates
26:32
Practical Ways to Achieve Targets in Diabetes Care
Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity
Feat.
S. Nissen
44:41
Norman Lepor
Obesity: New Understanding and Treatments
06:31
Susan Brian
Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist
05:08
Susan Brian
The Differences Between the Products of GLP1's and GLP/GIPs
12:19
Omnipod®
Optimizing Omnipod 5 Therapy: Case Studies - TCOYD
Feat.
S. Edelman,
J. Pettus
10:14
Omnipod®
Automated Insulin Delivery Systems: The Omnipod 5 - TCOYD
Feat.
S. Edelman,
J. Pettus
23:35
Canadian Collaborative Research Network
Is Obesity Management the Next Frontier?
Feat.
A. Michael Lincoff
36:34
Scripps Health
GLP-1 Hysteria
Feat.
S. Harris
08:21
Omnipod®
The Omnipod 5 Algorithm: How it Works - TCOYD
Feat.
S. Edelman,
J. Pettus
21:10
National Lipid Association
Plant-based Diets for Improving Lipids
Feat.
K. Williams